Abbvie

Skyrizi

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Skyrizi – J2327

Manufacturer:

Abbvie

Name:

Skyrizi

HCPCS Code Descriptor:

Injection, risankizumab-rzaa, intravenous, 1 mg

Category:

J Code

HCPCS:

J2327

NDC(s):

00074-1050-01, 00074-1065-01, 00074-1070-01, 00074-2100-01, 00074-5015-01

Primary Type:

Immunology:Anti-TNF

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

Skyrizi is an Immunology:Anti-TNF drug manufactured by Abbvie and administered via the Subcutaneous route of administration. The J Code: J2327 is aligned to the drug Skyrizi.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/23

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Inj risankizumab-rzaa 1 mg

Billing and Coding Guide:

https://www.skyrizihcp.com/content/dam/skyrizihcpivy/docs/billing-coding-guide.pdf

Patient Assistance:

https://www.abbvie.com/patients/patient-assistance.html